الصفحة الرئيسية>>Signaling Pathways>> Neuroscience>> Neurokinin Receptor>>Vofopitant dihydrochloride

Vofopitant dihydrochloride (Synonyms: GR 205171A)

رقم الكتالوجGC37918

ثنائي هيدروكلوريد Vofopitant (GR 205171A) هو مضاد لمستقبلات تاكيكينين نيوروكينين 1 (NK1) قوي وانتقائي ومتوفر عن طريق الفم ، ويمنع ارتباط [3H] SP بمستقبل NK1 مع قيم pKi البالغة 9.5 و 10.6 في أغشية الفئران والأغشية البشرية على التوالي ، عامل محتمل مضاد للقيء واسع الطيف

Products are for research use only. Not for human use. We do not sell to patients.

Vofopitant dihydrochloride التركيب الكيميائي

Cas No.: 168266-51-1

الحجم السعر المخزون الكميّة
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Vofopitant dihydrochloride (GR 205171A) is a potent, selective and orally available tachykinin neurokinin 1(NK1) receptor antagonist, inhibits [3H]SP binding to the NK1 receptor with pKi values of 9.5 and 10.6 in rat and human membranes respectively, acts as a potential broad-spectrum anti-emetic agent[1]. pKi: 9.5 (NK1, rat), 10.6 (NK1, human)[1]

[1]. Gardner CJ, et al. GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept. 1996 Aug 27;65(1):45-53.

مراجعات

Review for Vofopitant dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Vofopitant dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.